NCT02963402View on ClinicalTrials.gov

Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

November 9, 2016

Primary Completion Date

October 1, 2018

Study Completion Date

October 1, 2018

Conditions
Arthritis,Rheumatoid
Interventions
DRUG

Tocilizumab

DRUG

Adalimumab

Trial Locations (1)

08025

Insitut de Recerca Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors
lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT02963402 - Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab | Biotech Hunter | Biotech Hunter